PTM Therapeutics, Inc.
2 known investors
PTM Therapeutics is a biotech company developing therapeutic antibodies that target Post Translational Modifications (PTMs) to create more disease-specific targets. Its pipeline includes programs for inflammatory bowel disease/ulcerative colitis and metastatic colon cancer.
Biotech
Investors · 2
Frequently asked questions
- What does PTM Therapeutics, Inc. do?
- PTM Therapeutics is a biotech company developing therapeutic antibodies that target Post Translational Modifications (PTMs) to create more disease-specific targets. Its pipeline includes programs for inflammatory bowel disease/ulcerative colitis and metastatic colon cancer.
- Who are PTM Therapeutics, Inc.'s investors?
- PTM Therapeutics, Inc.'s investors include BioBrit, BioRock Ventures.